Find a job

Subscribe for free

All things Pharma

FDA approves pain management device

A new locking system for the world’s first rechargeable Spinal Cord Stimulator (SCS) device for chronic pain management has been approved in the US.

Boston Scientific’s Clik Anchor for its Precision Plus SCS System is to be launched in America, following FDA approval.

The device features an “innovative locking system designed to improve lead anchoring speed and consistency”, the company said in a statement.

Spinal Cord Stimulation is a reversible therapy that manages pain through an implantable pulse generator and external devices that control therapy and charge an implant.

“The Clik Anchor is easy to use and gives me confidence that the lead is secure,” said Salim Hayek, MD, of the University Hospitals Case Medical Center in Cleveland, Ohio. “This new product will benefit my patients and my practice with simpler, more consistent lead anchoring.”

The product will be launched at the American Academy of Pain Medicine Annual Meeting in Washington DC.

Michael Onuscheck, Senior Vice President and President of Boston Scientific’s Neuromodulation Division, said: “With approval and launch of the Clik Anchor, we have added six new products to our Neuromodulation portfolio in the past year.

“The Clik Anchor complements our SCS percutaneous leads portfolio, and gives physicians the most comprehensive array of lead options in the market.”

The Precision Plus SCS System is indicated as an aid in managing chronic intractable pain of the trunk and/or limbs.


Boston Scientific’s Precision spinal cord stimulation system

- Advertisement -


- Advertisement -



Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription